Novo Nordisk A/S
NYSE NVO · Bagsvaerd Denmark, Denmark
Works in Cardiovascular · Dermatology · Genetic & rare · GI & liver · Hematology · Immunology · Metabolic & endocrine · Musculoskeletal · Neurology · Oncology · Psychiatry · Renal & urogenital · Respiratory · Women's health
Novo Nordisk A/S is a clinical trial sponsor based in Bagsvaerd Denmark, Denmark, listed as NYSE NVO. It has 135 active clinical trials with 94,733,633 planned participants, across 14 therapeutic areas. Since 2021 it has completed 394 trials and stopped 19 early. Its FDA record on file shows 1 inspection.
Trial track record · since 2021
FDA record
Recent FDA actions
Financials · NYSE NVO
Pipeline · 135 active trials
| Stage | Trial | Status |
|---|---|---|
Questions about Novo Nordisk A/S
No warning letter naming Novo Nordisk A/S is on file. FDA has published 1 inspection classification naming it.
FDA has posted 1 inspection classification naming Novo Nordisk A/S. The latest inspection ended on 2026-04-17 and was classified VAI (voluntary action indicated). FDA posts a classification after its review, often months after the inspection ended.
Novo Nordisk A/S is lead sponsor of 135 active clinical trials on ClinicalTrials.gov, with 94,733,633 planned participants, in Cardiovascular, Dermatology, Genetic & rare, GI & liver and other areas. Since 2021 it has completed 394 trials and stopped 19 early.
Novo Nordisk A/S is based in Bagsvaerd Denmark, Denmark and is listed as NYSE NVO. The address is the one on its SEC filings, which name the establishment or the registrant, not always the group's head office.
From public sources only: ClinicalTrials.gov for trials, FDA's Data Dashboard, warning-letter listing and enforcement reports for the FDA record, and SEC filings for financials. Approve Suite is not affiliated with Novo Nordisk A/S; every record links to the source, and nothing here is advice.
See the rest of this profile
A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.
Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-10-16.
The FDA record counts inspection classifications, warning letters and recalls FDA has published that name this company. Compare it with the industry in the free CDMO FDA inspection lookup.
Approve Suite is not affiliated with Novo Nordisk A/S. Informational only.
See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.